Treatment-emergent adverse events occurred in 87.5% of the ipamorelin group and 94.8% of the placebo group
For people with eating disorders, these "ordinary" side effects land differently
This meta-analysis revealed that L-carnitine supplementation significantly reduces levels of triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), fasting blood glucose (FBG), HbA1c, HOMA-IR, C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-), as well as weight, body mass index (BMI), body fat percentage (BFP), and leptin in patients with diabetes and impaired glucose tolerance
Pharmacokinetically, Ipamorelin presents a short plasma half-life of approximately 2 hours, with a GH peak observed 30-45 minutes after subcutaneous injection